Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Accel Entertainment | ACEL | Jun 26, 2024 | 10.07 | +0.20 |
Accelerate Diagnostics | AXDX | Jun 26, 2024 | 1.17 | 0.00 |
Accenture A | ACN | Jun 26, 2024 | 304.62 | -0.83 |
Acco Brands | ACCO | Jun 26, 2024 | 4.68 | +1.96 |
Accolade | ACCD | Jun 26, 2024 | 6.13 | +2.68 |
Accuray | ARAY | Jun 26, 2024 | 1.79 | +8.48 |
Ace Global Business Acquisition | ACBA | Jun 26, 2024 | 12.03 | 0.00 |
Ace Global Business Acquisition Unit | ACBAU | Jun 26, 2024 | 12.00 | 0.00 |
Acelyrin | SLRN | Jun 26, 2024 | 3.86 | -1.03 |
Achieve Life Sciences | ACHV | Jun 26, 2024 | 4.76 | +2.59 |
Achilles Therapeutics ADR | ACHL | Jun 26, 2024 | 0.84 | -2.89 |
ACI Worldwide | ACIW | Jun 26, 2024 | 38.06 | +1.01 |
Aclarion | ACON | Jun 26, 2024 | 0.31 | +6.34 |
Aclaris Therapeutics | ACRS | Jun 26, 2024 | 1.12 | -13.57 |
ACM Research A | ACMR | Jun 26, 2024 | 21.88 | +0.14 |
Acme United | ACU | Jun 26, 2024 | 34.32 | +2.23 |
ACNB | ACNB | Jun 26, 2024 | 32.84 | +1.05 |
ACRES Commercial Realty | ACR | Jun 26, 2024 | 12.74 | -1.24 |
ACRES Commercial Realty C Pref | ACR-C | Jun 26, 2024 | 25.04 | 0.00 |
ACRES Commercial Realty D Pref | ACR-D | Jun 26, 2024 | 21.80 | -0.40 |
Acrivon Therapeutics | ACRV | Jun 26, 2024 | 5.80 | -4.29 |
Actelis Networks | ASNS | Jun 26, 2024 | 1.45 | -5.84 |
Actinium Pharmaceuticals | ATNM | Jun 26, 2024 | 7.37 | +2.93 |
Active Bear ETF | HDGE | Jun 26, 2024 | 20.91 | -0.81 |
Active U.S. Real Estate Powershares | PSR | Jun 26, 2024 | 84.10 | -0.24 |
Acuity Brands | AYI | Jun 26, 2024 | 239.77 | +0.94 |
Acumen Pharmaceuticals | ABOS | Jun 26, 2024 | 2.16 | +0.93 |
Acurx Pharmaceuticals | ACXP | Jun 26, 2024 | 2.24 | +3.23 |
Acushnet | GOLF | Jun 26, 2024 | 65.26 | -0.29 |
ACV Auctions A | ACVA | Jun 26, 2024 | 18.01 | +0.84 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.